August 2014 FDA Recall Drug by Akorn, Inc.
D-1571-2014 - Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point

This Class III drug recall was voluntarily initiated by Akorn, Inc. on August 5, 2014 for the product Drug. The FDA reported the reason for recall as failed impurity/degradation specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1571-2014

Reason for Recall
Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point
Initiated
08-05-2014
Reported
10-01-2014
Quantity
5,539 vials

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Rifampin for Injection USP, 600 mg*/vial (Sterile), supplied in sterile glass vials, Rx only For IV Infusion only, individually boxed, Mfd. for: Akorn, Inc., Lake Forest, IL --- NDC 17478-151-42

Batch or Lot Expiration Information

Lot# Lot: 12RIF4A, Expiration Date: 9/30/2014